Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra and Pegsunercept in Rheumatoid Arthritis
NCT00537667Phase 2Terminated
- Sponsor
- Amgen
- Start
- Aug 2001
- Primary completion
- Mar 2003
- Modality
- PEGylated Peptides, Fc-Fusion Proteins
01
Overview
A Phase 2 trial of pegsunercept in rheumatoid arthritis (RA), sponsored by Amgen. Started Aug 2001; status: terminated.
02
Drugs
pegsunercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00537667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00537667.